ICU Medical Total Assets 2006-2019 | ICUI

ICU Medical total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
ICU Medical Annual Total Assets
(Millions of US $)
2018 $1,585
2017 $1,497
2016 $705
2015 $627
2014 $541
2013 $500
2012 $429
2011 $361
2010 $310
2009 $309
2008 $283
2007 $243
2006 $244
2005 $205
ICU Medical Quarterly Total Assets
(Millions of US $)
Q2 2019 $1,623
Q1 2019 $1,613
Q4 2018 $1,585
Q3 2018 $1,545
Q2 2018 $1,526
Q1 2018 $1,493
Q4 2017 $1,497
Q3 2017 $1,523
Q2 2017 $1,487
Q1 2017 $1,473
Q4 2016 $705
Q3 2016 $689
Q2 2016 $663
Q1 2016 $636
Q4 2015 $627
Q3 2015 $610
Q2 2015 $570
Q1 2015 $554
Q4 2014 $541
Q3 2014 $528
Q2 2014 $520
Q1 2014 $506
Q4 2013 $500
Q3 2013 $469
Q2 2013 $452
Q1 2013 $438
Q4 2012 $429
Q3 2012 $413
Q2 2012 $393
Q1 2012 $376
Q4 2011 $361
Q3 2011 $344
Q2 2011 $346
Q1 2011 $329
Q4 2010 $310
Q3 2010 $300
Q2 2010 $287
Q1 2010 $287
Q4 2009 $309
Q3 2009 $310
Q2 2009 $299
Q1 2009 $294
Q4 2008 $283
Q3 2008 $270
Q2 2008 $260
Q1 2008 $247
Q4 2007 $243
Q3 2007 $247
Q2 2007 $257
Q1 2007 $249
Q4 2006 $244
Q3 2006 $236
Q2 2006 $228
Q1 2006 $215
Q4 2005 $205
Q3 2005 $192
Q2 2005 $186
Q1 2005 $173
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.170B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.337B 20.26
Abbott Laboratories (ABT) United States $140.738B 26.45
Stryker (SYK) United States $79.987B 27.66
Boston Scientific (BSX) United States $53.253B 25.83
Baxter (BAX) United States $44.944B 27.25
EssilorLuxottica Societe Anonyme (ESLOY) France $32.375B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.93
Coloplast (CLPBY) Denmark $24.818B 39.62
Lonza Group Ag (LZAGY) Switzerland $24.634B 0.00
Terumo (TRUMY) Japan $23.332B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.543B 0.00
ResMed (RMD) United States $18.641B 35.52
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.871B 52.91
Insulet (PODD) United States $9.245B 547.82
Perrigo (PRGO) Ireland $7.271B 13.39
Canopy Growth (CGC) Canada $6.759B 0.00
Hill-Rom Holdings (HRC) United States $6.636B 19.78
Haemonetics (HAE) United States $6.525B 49.24
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Neogen (NEOG) United States $3.350B 56.05
NuVasive (NUVA) United States $3.316B 26.44
Quidel (QDEL) United States $2.389B 23.72
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.290B 0.00
Agios Pharmaceuticals (AGIO) United States $1.917B 0.00
National Vision Holdings (EYE) United States $1.879B 40.56
Cardiovascular Systems (CSII) United States $1.641B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.080B 24.88
AtriCure (ATRC) United States $1.009B 0.00
Phibro Animal Health (PAHC) United States $0.855B 13.90
Eagle Pharmaceuticals (EGRX) United States $0.821B 20.92
Omeros (OMER) United States $0.756B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Lantheus Holdings (LNTH) United States $0.737B 19.38
PetIQ (PETQ) United States $0.712B 16.81
Cerus (CERS) United States $0.630B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.86
Surmodics (SRDX) United States $0.573B 109.00
MacroGenics (MGNX) United States $0.556B 0.00
Quanterix (QTRX) United States $0.547B 0.00
TG Therapeutics (TGTX) United States $0.493B 0.00
OraSure Technologies (OSUR) United States $0.475B 22.00
Owens & Minor (OMI) United States $0.399B 11.94
Meridian Bioscience (VIVO) United States $0.382B 11.93
Zynex (ZYXI) United States $0.379B 40.31
Utah Medical Products (UTMD) United States $0.347B 25.45
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.311B 0.00
BioLife Solutions (BLFS) United States $0.309B 95.06
United Health Products (UEEC) United States $0.245B 0.00
Bovie Medical (APYX) United States $0.235B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.160B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.128B 9.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.085B 20.14
Nephros (NEPH) United States $0.071B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.034B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00